DFP

Flaherty & Crumrine Dynamic Preferred & Income Fund Inc

NYSE · CIK 0001559991
$20.25 +0.05%
Vol
Inst. Holders3 funds
Inst. Value$8.7M
Inst. Activity2 buys / 1 sells
Exchange NYSE·CIK 0001559991·Prev Close $20.24

Recent Activity

Inst.
WELLS FARGO & COMPANY/MN — ADD
305,509 shares ($6.6M)
Inst.
BANK OF AMERICA CORP — TRIM
12,529 shares ($271.1K)

Top Institutional Holders

FundValueMove
WELLS FARGO & COMPANY/MN$5.8MADD
MORGAN STANLEY$2.7M
BANK OF AMERICA CORP$255.1KTRIM
3 institutional holders with $8.7M total value (420,668 shares) as of 2025-Q4. Top holders: WELLS, MORGAN, BANK.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1WELLS FARGO & COMPANY/MN279,231$5.8M66.4%ADD +62.4%
2MORGAN STANLEY129,167$2.7M30.7%
3BANK OF AMERICA CORP /DE/12,270$255.1K2.9%TRIM -29.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
WELLS FARGO & COMPANY/MNADD188,111305,509+62.4%$6.6M2025-Q3
BANK OF AMERICA CORP /DE/TRIM17,74812,529-29.4%$271.1K2025-Q3
UBS Group AGADD8,84311,480+29.8%$248.4K2025-Q3
FMR LLCNEAR_EXIT3,738400-89.3%$8.2K2025-Q2
FMR LLCNEW3,738$75.7K2025-Q1
UBS Group AGTRIM12,9018,321-35.5%$165.9K2024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.